Cargando…

Prognostic Value of PD-L1 Immunohistochemical Marker in Gastric Carcinoma and Its Correlation with HER2 Status

OBJECTIVE: Programmed death-ligand 1 (PD-L1) and human epidermal growth factor receptor 2 (HER2) are currently considered as prognostic markers and therapeutic targets in many human cancers. This study aims to evaluate immunohistochemical (IHC) expression of PD-L1 in gastric cancer (GC) and explore...

Descripción completa

Detalles Bibliográficos
Autores principales:	Attia, Samar, Abd El Hafez, Amal, Abdel-Aziz, Azza, Elmetwaly, Shimaa, Mokhtar, Nagwa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375601/ https://www.ncbi.nlm.nih.gov/pubmed/35485706 http://dx.doi.org/10.31557/APJCP.2022.23.4.1433

Ejemplares similares

Prognostic Value of Her2/neu Expression in Gastrointestinal Stromal Tumors: Immunohistochemical Study
por: Abd El-Aziz, Ahmed M, et al.
Publicado: (2017)

Immunohistochemical Expression of PD-L1 and IDH1 with Detection of MGMT Promoter Methylation in Astrocytoma
por: Hareedy, Amal Ahmed, et al.
Publicado: (2022)

HER-2/neu Marker Examination using Immunohistochemical Method in Patients Suffering from Gastric Adenocarcinoma
por: Movagharnejad, Kourosh, et al.
Publicado: (2013)

HER2 Oncogene Amplification and Immunohistochemical Profiling in Gastric Adenocarcinoma
por: Raj, Nisha, et al.
Publicado: (2018)

The Role of TROP2 in BCC and Cutaneous SCC: A Clinical and Immunohistochemical Study
por: Farag, Azza Gaber Antar, et al.
Publicado: (2021)

Immunohistochemical study on the prognostic value of MIB-1 in gastric carcinoma.
por: Müller, W., et al.
Publicado: (1996)

Immunohistochemical analysis of RTKs expression identified HER3 as a prognostic indicator of gastric cancer
por: Ema, Akira, et al.
Publicado: (2014)

Prognostic Value of Immunohistochemical Markers for Locally Advanced Rectal Cancer
por: Taha, Anas, et al.
Publicado: (2022)

Subtyping of high grade serous ovarian carcinoma: histopathological and immunohistochemical approach
por: Khashaba, Marwa, et al.
Publicado: (2022)

HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testing
por: Rüschoff, Josef, et al.
Publicado: (2010)

Primary Diagnosis of Epithelioid Hemangioendothelioma in Pleural Effusion Based on Cytologic Features and Vascular Marker Immunocytochemical Staining
por: Abd El hafez, Amal
Publicado: (2021)

Physical basis of the ‘magnification rule’ for standardized Immunohistochemical scoring of HER2 in breast and gastric cancer
por: Scheel, Andreas H., et al.
Publicado: (2018)

Significance of Detection of the HER2 Gene and PD-1/PD-L1 in Gastric Cancer
por: Yun, Tian, et al.
Publicado: (2020)

The predictive value of immunohistochemical markers in untreated Wilms’ tumour: are they useful?
por: Ghanem, Mazen A., et al.
Publicado: (2011)

Potential Role for a Panel of Immunohistochemical Markers in the Management of Endometrial Carcinoma
por: Salama, Amany, et al.
Publicado: (2019)

The Prognostic Value of Gastric Immune Prognostic Index in Gastric Cancer Patients Treated With PD-1/PD-L1 Inhibitors
por: Chen, Li, et al.
Publicado: (2022)

Can vitamin C affect the KBrO(3) induced oxidative stress on left ventricular myocardium of adult male albino rats? A histological and immunohistochemical study
por: El-Deeb, Mohammad E.E., et al.
Publicado: (2015)

High FOXA1 immunohistochemical expression level associates with mucinous histology, favorable clinico-pathological prognostic parameters and survival advantage in epithelial ovarian cancer
por: Sheta, Heba, et al.
Publicado: (2021)

Patterns of Immunohistochemical Expression of P53, BCL2, PTEN, and HER2/neu Tumor Markers in Specific Breast Cancer Lesions
por: Bealy, Mohamed Ahmed, et al.
Publicado: (2022)

Immunohistochemical Assessment of HER3 Expression in Odontogenic Cysts
por: Honarmand, Marieh, et al.
Publicado: (2015)

Positive prognostic value of HER2-HER3 co-expression and p-mTOR in gastric cancer patients
por: Cao, Guo-dong, et al.
Publicado: (2017)

Importance of formalin fixing conditions for HER2 testing in gastric cancer: immunohistochemical staining and fluorescence in situ hybridization
por: Yamashita-Kashima, Yoriko, et al.
Publicado: (2014)

Prognostic value of the immunohistochemical score based on four markers in head and neck squamous cell carcinoma
por: Xu, Qing-Qing, et al.
Publicado: (2023)

Immunohistochemical Expression of Calmodulin in Cutaneous Lichen Planus: A Case–Control Study
por: Ibrahim, Zeinab Abd El-Samad, et al.
Publicado: (2019)

Immunohistochemical expression and prognostic value of PD-L1 in Extrapulmonary small cell carcinoma: a single institution experience
por: Salhab, Mohammed, et al.
Publicado: (2018)

Evaluation of the Potential Prognostic Value of Tumor Budding in Laryngeal Carcinoma by Conventional and Immunohistochemical Staining
por: Abd Raboh, Nermine M., et al.
Publicado: (2020)

Beyond Chemotherapy, PD-1, and HER-2: Novel Targets for Gastric and Esophageal Cancer
por: Siddiqui, Ali Zubair, et al.
Publicado: (2021)

Expression of Programmed Death Ligand1 (PD-L1) in Gastric Carcinoma (Histopathological and Immunohistochemical Study)
por: Ali, Safa Mohammed, et al.
Publicado: (2023)

Immunohistochemical expression of vegf and her-2 proteins in osteosarcoma biopsies
por: Becker, Ricardo Gehrke, et al.
Publicado: (2013)

Immunohistochemical evaluation of HER2 expression in canine thyroid carcinoma
por: Yoshimoto, Sho, et al.
Publicado: (2019)

An immunohistochemical study of HER2 expression in primary brain tumors
por: Ramezani, Mazaher, et al.
Publicado: (2020)

Erratum to: Importance of formalin fixing conditions for HER2 testing in gastric cancer: immunohistochemical staining and fluorescence in situ hybridization
por: Yamashita-Kashima, Yoriko, et al.
Publicado: (2014)

Clinicopathological values of PD-L1 expression in HER2-positive breast cancer
por: Kurozumi, Sasagu, et al.
Publicado: (2019)

EGFR, CD10 and proliferation marker Ki67 expression in ameloblastoma: possible role in local recurrence
por: Abdel-Aziz, Azza, et al.
Publicado: (2012)

Immunohistochemical Markers in Endometrial Cancer
por: Mais, Valerio, et al.
Publicado: (2021)

Prognostic value of RGS1 and mTOR Immunohistochemical expression in Egyptian multiple myeloma patients; A single center study
por: Hafez, Nora, et al.
Publicado: (2023)

Correlation of PD-L1 immunohistochemical expression with microsatellite instability and p53 status in endometrial carcinoma
por: Arafa, Mohammad, et al.
Publicado: (2022)

Immunohistochemical Screening of HER2 in Canine Carcinomas: A Preliminary Study
por: Brunetti, Barbara, et al.
Publicado: (2021)

Ceratonia siliqua pods (Carob) methanol extract alleviates doxorubicin-induced nephrotoxicity via antioxidant, anti-inflammatory and anti-apoptotic pathways in rats
por: Atta, Attia H., et al.
Publicado: (2023)

Immunohistochemical Study of the PD-1/PD-L1 Pathway in Cutaneous Lupus Erythematosus
por: Király, Zsófia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1cgj0rlgln3cm46muceam76rkd